Loading organizations...
Loading organizations...
Biotechnology company developing long-acting drug-delivery technologies.
Prolynx has raised $70.0M across 1 funding round.
Prolynx has raised $70.0M in total across 1 funding round.
Prolynx has raised $70.0M in total across 1 funding round.
Prolynx's investors include Kush Parmar, Peter Thompson, Fred Cohen.
Prolynx has raised $70.0M across 1 funding round. Most recently, it raised $70.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 11, 2025 | $70.0M Series A | Kush Parmar, Peter Thompson | Fred Cohen |